BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 12093053)

  • 1. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal proatrial natriuretic peptide predicts two-year remodelling in patients with acute transmural myocardial infarction.
    Hole T; Hall C; Skaerpe T
    Eur Heart J; 2004 Mar; 25(5):416-23. PubMed ID: 15033254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
    Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
    Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B; Hall C
    J Card Fail; 2000 Sep; 6(3):208-13. PubMed ID: 10997746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between serial changes in left-sided heart chambers and atrial natriuretic peptide and N-terminal pro atrial natriuretic peptide after a first myocardial infarction. An echocardiographic study.
    Svanegaard J; Johansen JB; Klitgaard NA; Thayssen P; Haghfelt T
    Scand Cardiovasc J; 1999; 33(6):355-61. PubMed ID: 10622548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.
    Bonarjee VV; Omland T; Nilsen DW; Caidahl K; Sundsfjord JA; Dickstein K
    Br Heart J; 1995 Jun; 73(6):511-6. PubMed ID: 7626348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are changes in left ventricular volume as measured with the biplane Simpson's method predominantly related to changes in its area or long axis in the prognostic evaluation of remodelling following a myocardial infarction?
    Otterstad JE; St John Sutton M; Frøland G; Skjaerpe T; Graving B; Holmes I
    Eur J Echocardiogr; 2001 Jun; 2(2):118-25. PubMed ID: 11882438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal proatrial natriuretic peptide in primary care: relation to echocardiographic indices of cardiac function in mild to moderate cardiac disease.
    Hall C; Ihlen H; Bonarjee V; Dickstein K; Kjekshus J
    Int J Cardiol; 2003 Jun; 89(2-3):197-205. PubMed ID: 12767543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiography or Nt-proANP in post-myocardial infarction patients: is one enough?
    Pinto FJ
    Eur Heart J; 2002 Jul; 23(13):996-7. PubMed ID: 12093047
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
    Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
    J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
    Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
    Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular volumes, ejection fraction, and plasma proatrial natriuretic factor (1-98) after withdrawal of enalapril treatment initiated early after myocardial infarction. CONSENSUS II Multi-Echo Study Group.
    Bonarjee VV; Omland T; Nilsen DW; Carstensen S; Berning J; Edner M; Caidahl K
    Br Heart J; 1995 Jun; 73(6):506-10. PubMed ID: 7626347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal probrain natriuretic peptide predicts adverse outcomes in acute-myocardial infarction even with preserved left ventricular ejection fraction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2006; 58(2):138-43. PubMed ID: 18989058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between echocardiographic measurements of left ventricular dimensions and function by local investigators and a core laboratory in a 2-year follow-up study of patients with an acute myocardial infarction.
    Hole T; Otterstad JE; St John Sutton M; Frøland G; Holme I; Skjaerpe T
    Eur J Echocardiogr; 2002 Dec; 3(4):263-70. PubMed ID: 12413441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction.
    Uusimaa P; Ruskoaho H; Vuolteenaho O; Niemelä M; Lumme J; Ikäheimo M; Jounela A; Peuhkurinen K
    Int J Cardiol; 1999 Apr; 69(1):5-14. PubMed ID: 10362366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
    Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
    Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Bégué C; Mörner S; Brito D; Hengstenberg C; Cleland JGF; Arbustini E; Galve E; Wichter T; Richter A; Golmard JL; Bernard M; Dubourg O; Komajda M; Charron P; Isnard R
    Heart; 2020 Feb; 106(3):196-202. PubMed ID: 31350276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
    Talwar S; Squire IB; Downie PF; Mccullough AM; Campton MC; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 2000 Sep; 21(18):1514-21. PubMed ID: 10973765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
    Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
    Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.